US20090022894A1 - Thermally Resistant Anaerobically Curable Compositions - Google Patents

Thermally Resistant Anaerobically Curable Compositions Download PDF

Info

Publication number
US20090022894A1
US20090022894A1 US11/778,190 US77819007A US2009022894A1 US 20090022894 A1 US20090022894 A1 US 20090022894A1 US 77819007 A US77819007 A US 77819007A US 2009022894 A1 US2009022894 A1 US 2009022894A1
Authority
US
United States
Prior art keywords
meth
group
composition according
weight percent
anaerobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/778,190
Inventor
Shabbir Attarwala
Qinyan Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel IP and Holding GmbH
Original Assignee
Henkel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Corp filed Critical Henkel Corp
Priority to US11/778,190 priority Critical patent/US20090022894A1/en
Assigned to HENKEL CORPORATION reassignment HENKEL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ATTARWALA, SHABBIR, ZHU, QINYAN
Assigned to HENKEL CORPORATION reassignment HENKEL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHINDLER, KLAUS
Priority to CN200880024813.7A priority patent/CN101743260B/en
Priority to KR1020107003244A priority patent/KR101520513B1/en
Priority to JP2010516998A priority patent/JP5697977B2/en
Priority to PCT/US2008/008582 priority patent/WO2009011819A2/en
Priority to CA2691947A priority patent/CA2691947C/en
Publication of US20090022894A1 publication Critical patent/US20090022894A1/en
Assigned to Henkel US IP LLC reassignment Henkel US IP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HENKEL CORPORATION
Assigned to Henkel IP & Holding GmbH reassignment Henkel IP & Holding GmbH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Henkel US IP LLC
Priority to US15/145,167 priority patent/US10100226B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J4/00Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/40Redox systems
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/14Methyl esters, e.g. methyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/38Boron-containing compounds

Definitions

  • the present invention relates to anaerobically curable compositions demonstrating resistance to elevated temperature conditions.
  • Anaerobic adhesive compositions generally are well-known. See e.g., R. D. Rich, “Anaerobic Adhesives” in Handbook of Adhesive Technology, 29, 467-79, A. Pizzi and K. L. Mittal, eds., Marcel Dekker, Inc., New York (1994), and references cited therein. Their uses are legion and new applications continue to be developed.
  • anaerobic adhesives ordinarily include a free-radically polymerizable acrylate ester monomer, together with a peroxy initiator and an inhibitor component. Oftentimes, such anaerobic adhesive compositions also contain accelerator components to increase the speed with which the composition cures.
  • U.S. Pat. No. 6,342,545 discloses and claims a radical curable composition, radical cured reaction products of which demonstrate improved adhesion and resistance to thermal degradation at elevated temperatures.
  • the composition which may cure under anaerobic conditions, includes (a) a (meth)acrylate component; (b) an effective amount of latent imidazole as a thermal resistance conferring agent; and (c) a radical cure-inducing composition, such as an anaerobic cure-inducing composition.
  • the latent imidazole is an adduct obtained by a reacting a compound having an active hydrogen together with a tertiary amino group, an epoxy compound and a carboxcylic acid anhydride.
  • the thermal resistance-conferring agent is selected from methyl imidizole, benzoyl imidizole, benzoyl methylimidizole, phthaloyl diimidizole and combinations thereof.
  • U.S. Pat. No. 6,150,479 also discloses and claims a radical curable composition, radical cured reaction products of which demonstrate improved adhesion and resistance to thermal degradation at elevated temperatures.
  • the composition which may cure under anaerobic conditions, includes (a) a (meth)acrylate component; (b) a coreactant component of certain structures, examples of which include epoxidized citronellyl acrylate; epoxidized citronellyl metehacrylate; cyclohexenyl methanol acrylate; cyclohexenyl methanol methacrylate; epoxidized cyclohexenyl methanol methacrylate; dihydrodicyclopentadienyl acrylate; edoxidized dihydrodicyclopentadienyl acrylate; dihydrodicylopentadienyl methacrylate; epoxidized dihydrodicylopentadienyl methacrylate; e
  • compositions may also include a thermal resistance-conferring agent, such as one selected from imidizole derivatives (such as benzoyl imidizole, methyl imidizole, benzoyl methylimidizole, phthaloyl diimidizole and combinations thereof), latent imidizoles, and an adduct obtained by reacting a compound having an active hydrogen together with a tertiary amino group in the molecule, an epoxy compound and a carboxylic acid anhydride.
  • imidizole derivatives such as benzoyl imidizole, methyl imidizole, benzoyl methylimidizole, phthaloyl diimidizole and combinations thereof
  • latent imidizoles such as latent imidizoles, and an adduct obtained by reacting a compound having an active hydrogen together with a tertiary amino group in the molecule, an epoxy compound and a carboxylic acid anhydride.
  • PST with boric acid (Item No. 190901), which has among other components about 1-5% of boric acid.
  • U.S. Pat. Nos. 4,320,221 (Hoffmann) and 4,451,627 (Frisch) disclose anaerobic adhesives made from reaction products of isocyantes with a “polyahl”.
  • the term “polyahl” is said to generally include any polyfunctional compounds having an average greater than 1 active hydrogen moiety. Suitable compounds may be those with active hydrogens supplied from only one or from more than one type of active hydrogen moiety. Examples of compounds having more than one type of active hydrogen are reported to include amino alcohols and mercapto alcohols. Suitable polyahls also specifically include those compounds having 3 or more active hydrogen moieties per molecule. Esters of boric acid are mentioned as such reactants.
  • the Inventive anaerobically curable compositions include (a) a (meth)acrylate component; (b) an anaerobic cure-inducing composition; and (c) a component having the structural unit, HO—X(Y)—OH, where X is silicon or boron, and Y is ⁇ O, when X is silicon and Y is OH, when X is boron.
  • a component having the structural unit, HO—X(Y)—OH where X is silicon or boron, and Y is ⁇ O, when X is silicon and Y is OH, when X is boron.
  • the component is present in an amount within the range of about 25 weight percent to about 75 weight percent.
  • This invention also provides methods of preparing and using the inventive anaerobic curable compositions as well as reaction products of the inventive anaerobic curable compositions.
  • FIG. 1 depicts a chart of hot strength against temperature of control Sample No. 11 and Sample No. 12, within the scope of the invention.
  • the inventive anaerobically curable compositions include (a) a (meth)acrylate component; (b) an anaerobic cure-inducing composition; and (c) a component having the structural unit, MO—X(Y)—OMI, where M and M′ are independently selected from H, Na, K, or Li, X is silicon or boron, and Y is ⁇ O, when X is silicon and Y is OH, when X is boron. When X is boron and Y is OH, the component is present in an amount within the range of about 25 weight percent to about 75 weight percent.
  • the (meth)acrylate component may be chosen from a host of materials, such as those represented by H 2 O ⁇ CGCO 2 R 1 , where G may be hydrogen, halogen or alkyl groups having from 1 to about 4 carbon atoms, and R 1 may be selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkaryl, aralkyl or aryl groups having from 1 to about 16 carbon atoms, any of which may be optionally substituted or interrupted as the case may be with silane, silicon, oxygen, halogen, carbonyl, hydroxyl, ester, carboxylic acid, urea, urethane, carbonate, amine, amide, sulfur, sulfonate, sulfone and the like.
  • G may be hydrogen, halogen or alkyl groups having from 1 to about 4 carbon atoms
  • R 1 may be selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alka
  • Additional (meth)acrylate monomers suitable for use herein include polyfunctional (meth)acrylate monomers, such as, but not limited to, di- or tri-functional (meth)acrylates like polyethylene glycol di(meth)acrylates, tetrahydrofuran (meth)acrylates and di(meth)acrylates, hydroxypropyl (meth)acrylate (“HPMA”), hexanediol di(meth)acrylate, trimethylol propane tri(methyl/acrylate (“TMPTMA”), diethylene glycol dimethacrylate, triethylene glycol dimethacrylate (“TRIEGCV”), tetraethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, di-(pentanethylene glycol) dimethacrylate, tetraethylene diglycol diacrylate, diglycerol tetramethacrylate, tetramethylene dimethacrylate, ethylene dimethacrylate, neopentyl glycol diacryl
  • SiMA silicone (meth)acrylate moieties
  • the (meth)acrylate component should comprise from about 10 to about 75 weight percent of the composition, such as about 50 to about 70 weight percent, based on the total weight of the composition.
  • the component having boron or silicon as a central atom should be capable of forming a network under elevated temperature conditions. That is, when the component contains boron, and is thus boric acid, boric oxide or borax pentahydrate and salts thereof, the component can form a network when exposed to such elevated temperature conditions, which ordinarily are for purposes of the present invention as low as 200° C., but the time for such network formation decreases with an increase in temperature.
  • the component having boron or silicon as a central atom is a boron-containing one
  • the component should be present in the inventive composition in an amount within the range of about 25 weight percent to about 75 weight percent, such as about 35 weight percent to about 60 weight percent, for instance about 40 weight percent to about 50 weight percent, based on the total weight of the composition.
  • the component having boron or silicon as a central atom is a silicon-containing one
  • the component may be selected from silicic acid, sodium orthosilicate, Na 4 SiO 4 ; sodium metasilicate, Na 2 SiO 3 ; sodium polysilicate, (Na 2 SiO 3 ) n ; or sodium pyrosilicate, Na 6 Si 2 O 7 .
  • the component having boron or silicon as a central atom is a silicon-containing one
  • the component should be present in the inventive composition in an amount within the range of about 10 weight percent to about 75 weight percent, for instance about 25 weight percent to about 60 weight percent.
  • Desirable anaerobic cure-inducing compositions to induce and accelerate cure of the inventive compositions may include saccharin, toluidines, such as N,N-diethyl-p-toluidine (“DE-p-T”) and N,N-dimethyl-o-toluidine (“DM-o-T”), acetyl phenylhydrazine (“APH”), maleic acid, and stabilizers like quinones, such as napthaquinone and anthraquinone. See e.g. U.S. Pat. Nos. 3,218,305 (Krieble), 4,180,640 (Melody), 4,287,330 (Rich) and 4,321,349 (Rich).
  • toluidines such as N,N-diethyl-p-toluidine (“DE-p-T”) and N,N-dimethyl-o-toluidine (“DM-o-T”)
  • APH acetyl phenylhydrazine
  • R 1 -R 7 are each independently selected from hydrogen or C 1-4 ;
  • Z is a carbon-carbon single bond or carbon-carbon double bond;
  • m is 0 or 1; and
  • n is an integer between 1 and 5;
  • Y is an aromatic ring, optionally substituted at up to five positions by C 1-6 alkyl or alkoxy, or halo groups;
  • A is C ⁇ O, S ⁇ O or O ⁇ S ⁇ O;
  • X is NH, O or S and Z is an aromatic ring, optionally substituted at up to five positions by C 1-6 alkyl or alkoxy, or halo groups, or Y and Z taken together may join to the same aromatic ring or aromatic ring system, provided that when X is NH, o-benzoic sulfimide is excluded therefrom;
  • R is hydrogen, halogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, carboxyl, or sulfonato, and R 1 is as defined above and alkenyl, hydroxyalkyl, hydroxyalkenyl, or aralkyl. See U.S. Pat. Nos. 6,835,762, 6,897,277 and 6,958,368.
  • Loctite (R&D) Ltd. designed anaerobically curable compositions using the following trithiadiaza pentalenes as a cure accelerator:
  • a and A 1 may be selected from O and N;
  • R, R 1 , R 2 and R 3 may be the same or different, are as defined above and cycloalkyl, cycloalkenyl, and aryl, having from 1 to about 30 carbon atoms, and may be substituted or interrupted with a heteroatom, and heterocyclic structures, or
  • R 1 and R 3 taken together may join to form a cyclic structure having from about 20 to about 28 ring atoms, and together represent dialkyl substituted polyether structures that may be substituted or interrupted with the trithiadiaza pentalene structure, which itself may or may not be substituted by A 1 , R 2 , or R 3 , as defined above. See U.S. Pat. No. 6,583,289 (McArdle).
  • Triazine/thiol anaerobic cure systems may also be used in the practice of the present invention.
  • U.S. Pat. Nos. 4,413,108, 4,447,588, 4,500,608 and 4,528,059 each speak to such a system, and the entirety of each of which is hereby expressly incorporated herein by reference.
  • inventive compositions may also include other conventional components, such as metal catalysts, like iron and copper.
  • metal catalysts are generally undesirable in one-part anaerobic formulations (hence the use of sequestering agents to precipitate metals).
  • metal catalysts may be added to part of the formulation that does not contain an initiator, such as a peroxy compound.
  • a number of well-known initiators of free radical polymerization are typically incorporated into the inventive compositions including, without limitation, hydroperoxides, such as CHP, para-menthane hydroperoxide, t-butyl hydroperoxide (“TBH”) and t-butyl perbenzoate.
  • hydroperoxides such as CHP, para-menthane hydroperoxide, t-butyl hydroperoxide (“TBH”) and t-butyl perbenzoate.
  • peroxides include benzoyl peroxide, dibenzoyl peroxide, 1,3-bis(t-butylperoxyisopropyl)benzene, diacetyl peroxide, butyl 4,4-bis(t-butylperoxy)valerate, p-chlorobenzoyl peroxide, cumene hydroperoxide, t-butyl cumyl peroxide, t-butyl perbenzoate, di-t-butyl peroxide, dicumyl peroxide, 2,5-dimethyl-2,5-di-t-butylperoxyhexane, 2,5-dimethyl-2,5-di-t-butyl-peroxyhex-3-yne, 4-methyl-2,2-di-t-butylperoxypentane and combinations thereof.
  • the anaerobic cure-inducing composition may be used in amounts of about 0.1 to about 10 weight percent, such as about 1 to about 5 weight percent, based on the total weight of the composition.
  • Additional components have been included in traditional anaerobic curable compositions to alter the physical properties of either the curable compositions or the reaction products thereof.
  • thickeners, non-reactive plasticizers, fillers, toughening components (such as elastomers and rubbers), and other well-known additives may be incorporated therein where the art-skilled person believes it would be desirable to do so.
  • a coreactant may be chosen from those disclosed and described in U.S. Pat. Nos. 6,043,327 (Attarwala) and 6,391,993 (Attarwala), the disclosures of each of which being expressly incorporated herein by reference.
  • the coreactant may be selected from
  • X can be present at least once (i.e., mono-, di, or tri-substituted) and may be chosen from H or D n A, where n can range between 0 and 1, with at least one X being D n A.
  • n can range between 0 and 1, with at least one X being D n A.
  • A can be represented by structure III below:
  • E can be a member selected from H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to 20 carbon atoms with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate.
  • R can be selected from H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to about 20 carbon atoms, with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate.
  • X 1 can be present at least once on structure II (i.e., mono-, di-, or tri-substituted) and may be chosen from H or O ⁇ CD n A, with at least one X 1 being O ⁇ CD n A, where D n and A can be as defined above.
  • Another suitable coreactant can be represented as:
  • D and A can be as described above and can be present at least once and can also be present together attached to ring atoms which are in alpha-beta relation to one another.
  • Examples of particular coreactant include, but are not limited to, those shown in formulas V-VII below.
  • TAC triallyl cyanurate
  • TAT- triallyl trimesate
  • TAI triallyl isocyanurate
  • the present invention also provides methods of preparing and using the inventive anaerobic adhesive compositions, as well as reaction products of the compositions.
  • compositions of the present invention may be prepared using conventional methods which are well known to those persons of skill in the art.
  • the components of the inventive compositions may be mixed together in any convenient order consistent with the roles and functions the components are to perform in the compositions.
  • Conventional mixing techniques using known apparatus may be employed.
  • compositions of this invention may be applied to a variety of substrates to perform with the desired benefits and advantages described herein.
  • appropriate substrates may be constructed from steel, brass, copper, aluminum, zinc, glass and other metals and alloys, ceramics and thermosets.
  • the inventive compositions may have beneficial properties making them suitable for use in gasketing and composite applications.
  • the compositions of this invention demonstrate particularly good bond strength on steel and aluminum.
  • An appropriate primer may be applied to a surface of the chosen substrate to enhance the cure rate of the inventive compositions. See e.g. U.S. Pat. No. 5,811,473 (Ramos).
  • the invention also provides a process for preparing a reaction product from the anaerobic adhesive composition of the present invention, steps of which include applying the composition to a desired substrate surface and exposing the composition to an anaerobic environment for a time sufficient to cure the composition.
  • LOCTITE 272 is made from an aromatic dimethacrylate ester (CAS No. 24448-20-2) in an amount between 60-100% maleimide resin (CAS No. 3006-93-7) in an amount between 10-30%, hydroxyalkyl methacrylate (CAS No. 27813-02-1) in an amount between 1-5%, cumene hydroperoxide (CAS No. 80-15-9), in an amount between 1-5%, silica (amorphous, fumed, crystalline-free) (CAS No. 112945-52-5) in an amount between 1-5%, and APH (CAS No. 114-83-0) in an amount between 0.1-1%.
  • LOCTITE 272 was used as one control and is referred to as Sample No. 1. Sample Nos. 2-4 were formulated with LOCTITE 272 and the amount of boric acid shown.
  • Sample No. 1 demonstrated 107 in-lbs of breakaway strength after 4 hours at a temperature of 300° C. and only 12 in-lbs breakaway hot strength after 20 hours at a temperature of 300° C. At a temperature of 350° C., however, upon application to steel nuts and bolts Sample No. 1 demonstrated 26 in-lbs of breakaway strength after 4 hours at a temperature of 350° C. but no breakaway hot strength after 20 hours at a temperature of 350° C. Thus, in terms of retained strength, Sample No. 1 showed only 66 at 300° C. after the given time period and no retained strength at all at 350° C. after the given time period.
  • Sample Nos. 2, 3, and 4 demonstrated an increased retention in hot strength at higher temperatures and longer ageing times, as compared to Sample No. 1.
  • the significant improvement in percent hot strength retained at each of 300° C. and 350° C. heat ageing of Sample Nos. 3 and 4 are attributed in this invention to the 25% and 50% by weight, respectively, of boric acid in the samples.
  • Sample Nos. 5-7 and 9-10 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 350° C. for a period of time of 3 days.
  • Table 5A shows evaluation results, with Sample Nos. 9 and 10 demonstrating more than 50% hot strength retained under the test conditions, while Sample Nos. 5, 6 and 7 demonstrated below 40% hot strength retained under the same conditions.
  • Sample Nos. 5, 6 and 8 were evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 280° C. for a period of time of 24 hours.
  • Table 5B shows evaluation results, with Sample No. 6 and 8 demonstrating over 100% hot strength retained at a temperature of 280° C. after a period of time of 24 hours, while Sample No. 5 demonstrated 80% hot strength retained under the same conditions.
  • Sample Nos. 6, 7, 8 and 10 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of at 350° C. for a period of time of 24 hours Table 5C shows evaluation results of Sample Nos. 8 and 10 demonstrating more than 100% hot strength retained at 350° C. after hours, Sample Nos. 6 and 7 demonstrated less than less than 90% strength retained at the same conditions.
  • Example 3 from Table 1 at column 14 of U.S. Pat. No. 6,043,327, representative of LOCTITE 294, is reproduced as Sample No. 11 and a formulation within the scope of the invention is shown as Sample No. 12.
  • Sample No. 11 representative of LOCTITE 294, is used as a control and contains the combination of maleimide and TAC for controlled strength heat resistance, while Sample No. 12 contains the combination of boric acid and TAC for heat resistance.
  • Reference to Table 7 shows the hot breakloose strength of Sample No. 11 decreased at a temperature above 233° C., while the hot strength of Sample No. 12 was retained at temperatures up to 350° C. Reference also to FIG. 1 shows this data graphically, and highlights that the strength is by and large maintained over the temperature range evaluated.
  • Table No. 8 shows a comparison of two samples, one with silicic acid (Sample No. 13) and the other (Sample No. 5) as a control, without silicic acid.
  • Sample No. 13 was also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 350° C. for a period of time of 3 days.
  • Table 9 shows evaluation results, with Sample No. 13 surprisingly demonstrating 100% hot strength retained at 350° C. after 3 days, while Sample No. 5 demonstrated only 30% hot strength under the same conditions.
  • Sample Nos. 13 and 14 are presented, with Sample No. 14 being LOCTITE 510 Gasket Eliminator Flange Sealant and Sample No. 15 being 75% by weight LOCTITE 510 Gasket Eliminator Flange Sealant and 25% by weight sodium silicate powder.
  • Sample Nos. 13 and 14 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 233° C. for a period of time of 24 hours. Table 11 shows the evaluation results, with Sample No. 14 demonstrating improved strength retained at 233° C. for a period of time of 24 hours as compared to Sample No. 13.

Abstract

The present invention relates to anaerobically curable compositions demonstrating resistance to elevated temperature conditions.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to anaerobically curable compositions demonstrating resistance to elevated temperature conditions.
  • 2. Brief Description of Related Technology
  • Anaerobic adhesive compositions generally are well-known. See e.g., R. D. Rich, “Anaerobic Adhesives” in Handbook of Adhesive Technology, 29, 467-79, A. Pizzi and K. L. Mittal, eds., Marcel Dekker, Inc., New York (1994), and references cited therein. Their uses are legion and new applications continue to be developed.
  • Conventional anaerobic adhesives ordinarily include a free-radically polymerizable acrylate ester monomer, together with a peroxy initiator and an inhibitor component. Oftentimes, such anaerobic adhesive compositions also contain accelerator components to increase the speed with which the composition cures.
  • Many adhesives particularly anaerobic adhesives, have been rendered resistant to degradation at elevated temperatures by the inclusion of certain additives. For instance, U.S. Pat. No. 3,988,299 (Malofsky) refers to a heat curable composition having improved thermal properties, which includes certain acrylate monomers and maleimide compounds.
  • L. J. Baccel and B. M. Malofsky, “Anaerobic Adhesives Containing Maleimides Having Improved Thermal Resistance” in Adhesive Chemicals, 589-601, L-H, Lee, ed., Plenum Publishing Corp. (1984) report the use of maleimides—specifically, N-phenyl malelmlde, m-phenylene dimaleimide and a reaction product of methyleine dianlline and methylene dianiline bismaleimide—to increase the thermal resistance of anaerobic adhesives which are fully cured at temperatures of at least 150° C.
  • While the addition to anaerobic adhesive compositions of such maleimide compounds to render them resistant to thermal degradation provides reaction products with acceptable performance, it would be desirable to find alternative compounds to include in such formulations.
  • Henkel Corporation in the past designed certain anaerobic adhesive compositions with enhanced resistance to thermal degradation. For instance, U.S. Pat. No. 6,342,545 (Klemarczyk) discloses and claims a radical curable composition, radical cured reaction products of which demonstrate improved adhesion and resistance to thermal degradation at elevated temperatures. The composition, which may cure under anaerobic conditions, includes (a) a (meth)acrylate component; (b) an effective amount of latent imidazole as a thermal resistance conferring agent; and (c) a radical cure-inducing composition, such as an anaerobic cure-inducing composition. The latent imidazole is an adduct obtained by a reacting a compound having an active hydrogen together with a tertiary amino group, an epoxy compound and a carboxcylic acid anhydride. And the thermal resistance-conferring agent is selected from methyl imidizole, benzoyl imidizole, benzoyl methylimidizole, phthaloyl diimidizole and combinations thereof.
  • U.S. Pat. No. 6,150,479 (Klemarczyk) also discloses and claims a radical curable composition, radical cured reaction products of which demonstrate improved adhesion and resistance to thermal degradation at elevated temperatures. The composition, which may cure under anaerobic conditions, includes (a) a (meth)acrylate component; (b) a coreactant component of certain structures, examples of which include epoxidized citronellyl acrylate; epoxidized citronellyl metehacrylate; cyclohexenyl methanol acrylate; cyclohexenyl methanol methacrylate; epoxidized cyclohexenyl methanol methacrylate; dihydrodicyclopentadienyl acrylate; edoxidized dihydrodicyclopentadienyl acrylate; dihydrodicylopentadienyl methacrylate; epoxidized dihydrodicylopentadienyl methacrylate; epoxidized 2-propenoic acid, 2-[(3a,3,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl)oxy]ethyl ester; epoxidlzed 2-propenoic acid, 2-methyl-, 2-[(3a,3,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl)oxy]ethyl ester and combinations thereof; and (c) a radical cure-inducing composition, such as an anaerobic cure-inducing composition. Here, the presence of the coreactant in the composition provides radical cured reaction products thereof with improved adhesion and resistance to thermal degradation. The compositions may also include a thermal resistance-conferring agent, such as one selected from imidizole derivatives (such as benzoyl imidizole, methyl imidizole, benzoyl methylimidizole, phthaloyl diimidizole and combinations thereof), latent imidizoles, and an adduct obtained by reacting a compound having an active hydrogen together with a tertiary amino group in the molecule, an epoxy compound and a carboxylic acid anhydride.
  • Henkel also has sold and continues to sell a product called PST with boric acid (Item No. 190901), which has among other components about 1-5% of boric acid.
  • U.S. Pat. Nos. 4,320,221 (Hoffmann) and 4,451,627 (Frisch) disclose anaerobic adhesives made from reaction products of isocyantes with a “polyahl”. The term “polyahl” is said to generally include any polyfunctional compounds having an average greater than 1 active hydrogen moiety. Suitable compounds may be those with active hydrogens supplied from only one or from more than one type of active hydrogen moiety. Examples of compounds having more than one type of active hydrogen are reported to include amino alcohols and mercapto alcohols. Suitable polyahls also specifically include those compounds having 3 or more active hydrogen moieties per molecule. Esters of boric acid are mentioned as such reactants.
  • Despite the state of the art, there is an on-going search for additives to improve the thermal performance of reaction products of radical-curable adhesives, such as anaerobically curable ones.
  • SUMMARY OF THE INVENTION
  • The Inventive anaerobically curable compositions include (a) a (meth)acrylate component; (b) an anaerobic cure-inducing composition; and (c) a component having the structural unit, HO—X(Y)—OH, where X is silicon or boron, and Y is ═O, when X is silicon and Y is OH, when X is boron. When X is boron and Y is OH, the component is present in an amount within the range of about 25 weight percent to about 75 weight percent.
  • This invention also provides methods of preparing and using the inventive anaerobic curable compositions as well as reaction products of the inventive anaerobic curable compositions.
  • The present invention will be more fully appreciated by a reading of the “Detailed Description of the Invention”, and the illustrative examples which follow thereafter.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 depicts a chart of hot strength against temperature of control Sample No. 11 and Sample No. 12, within the scope of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The inventive anaerobically curable compositions include (a) a (meth)acrylate component; (b) an anaerobic cure-inducing composition; and (c) a component having the structural unit, MO—X(Y)—OMI, where M and M′ are independently selected from H, Na, K, or Li, X is silicon or boron, and Y is ═O, when X is silicon and Y is OH, when X is boron. When X is boron and Y is OH, the component is present in an amount within the range of about 25 weight percent to about 75 weight percent.
  • The (meth)acrylate component may be chosen from a host of materials, such as those represented by H2O═CGCO2R1, where G may be hydrogen, halogen or alkyl groups having from 1 to about 4 carbon atoms, and R1 may be selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkaryl, aralkyl or aryl groups having from 1 to about 16 carbon atoms, any of which may be optionally substituted or interrupted as the case may be with silane, silicon, oxygen, halogen, carbonyl, hydroxyl, ester, carboxylic acid, urea, urethane, carbonate, amine, amide, sulfur, sulfonate, sulfone and the like.
  • Additional (meth)acrylate monomers suitable for use herein include polyfunctional (meth)acrylate monomers, such as, but not limited to, di- or tri-functional (meth)acrylates like polyethylene glycol di(meth)acrylates, tetrahydrofuran (meth)acrylates and di(meth)acrylates, hydroxypropyl (meth)acrylate (“HPMA”), hexanediol di(meth)acrylate, trimethylol propane tri(methyl/acrylate (“TMPTMA”), diethylene glycol dimethacrylate, triethylene glycol dimethacrylate (“TRIEGCV”), tetraethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, di-(pentanethylene glycol) dimethacrylate, tetraethylene diglycol diacrylate, diglycerol tetramethacrylate, tetramethylene dimethacrylate, ethylene dimethacrylate, neopentyl glycol diacrylate, trimethylol propane triacrylate and bisphenol-A mono and di(meth)acrylates, such as ethoxylated bisphenol-A (meth)acrylate (“EBIPMA”) , and bisphenol-F mono and di(methiacrylates, such as ethoxylated bisphenol-F (meth)acrylate.
  • Still other (methlacrylate monomers that may be used herein include silicone (meth)acrylate moieties (“SiMA”), such as those taught by and claimed in U.S. Pat. No. 5,605,999 (Chu), the disclosure of which is hereby expressly incorporated herein by reference.
  • Of course, combinations of these (methacrylate monomers may also be used.
  • The (meth)acrylate component should comprise from about 10 to about 75 weight percent of the composition, such as about 50 to about 70 weight percent, based on the total weight of the composition.
  • The component having boron or silicon as a central atom should be capable of forming a network under elevated temperature conditions. That is, when the component contains boron, and is thus boric acid, boric oxide or borax pentahydrate and salts thereof, the component can form a network when exposed to such elevated temperature conditions, which ordinarily are for purposes of the present invention as low as 200° C., but the time for such network formation decreases with an increase in temperature.
  • While boric acids have been suggested for use in adhesives in the past (such as has been suggested by U.S. Borax Inc. for their OPTIBOR product), such adhesives have been starch based (ordinarily, aqueous systems' for the corrugated paper and paperboard industries. Additionally, U.S. Borax has promoted the OPTIBOR product as a peptizing agent in the manufacture of casein-based and dextrin-based adhesives. The OPTIBOR product is reported to improve the tack and green strength of the adhesive (again, an aqueous, starch-based one) by crosslinking conjugated hydroxyl groups.
  • Where the component having boron or silicon as a central atom is a boron-containing one, the component should be present in the inventive composition in an amount within the range of about 25 weight percent to about 75 weight percent, such as about 35 weight percent to about 60 weight percent, for instance about 40 weight percent to about 50 weight percent, based on the total weight of the composition.
  • Where the component having boron or silicon as a central atom is a silicon-containing one, the component may be selected from silicic acid, sodium orthosilicate, Na4SiO4; sodium metasilicate, Na2SiO3; sodium polysilicate, (Na2SiO3)n; or sodium pyrosilicate, Na6Si2O7.
  • Where the component having boron or silicon as a central atom is a silicon-containing one, the component should be present in the inventive composition in an amount within the range of about 10 weight percent to about 75 weight percent, for instance about 25 weight percent to about 60 weight percent.
  • Desirable anaerobic cure-inducing compositions to induce and accelerate cure of the inventive compositions may include saccharin, toluidines, such as N,N-diethyl-p-toluidine (“DE-p-T”) and N,N-dimethyl-o-toluidine (“DM-o-T”), acetyl phenylhydrazine (“APH”), maleic acid, and stabilizers like quinones, such as napthaquinone and anthraquinone. See e.g. U.S. Pat. Nos. 3,218,305 (Krieble), 4,180,640 (Melody), 4,287,330 (Rich) and 4,321,349 (Rich).
  • In addition to the components listed in the preceding paragraph as constituents of anaerobic cure-inducing compositions, more recently Henkel Corporation has discovered a series of anaerobic cure accelerators, some of which are set forth below:
  • Figure US20090022894A1-20090122-C00001
  • where R1-R7 are each independently selected from hydrogen or C1-4; Z is a carbon-carbon single bond or carbon-carbon double bond; m is 0 or 1; and n is an integer between 1 and 5;
  • Figure US20090022894A1-20090122-C00002
  • where Y is an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups; A is C═O, S═O or O═S═O; X is NH, O or S and Z is an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups, or Y and Z taken together may join to the same aromatic ring or aromatic ring system, provided that when X is NH, o-benzoic sulfimide is excluded therefrom;
  • Figure US20090022894A1-20090122-C00003
  • where R is hydrogen, halogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, carboxyl, or sulfonato, and R1 is as defined above and alkenyl, hydroxyalkyl, hydroxyalkenyl, or aralkyl. See U.S. Pat. Nos. 6,835,762, 6,897,277 and 6,958,368.
  • In addition, Loctite (R&D) Ltd. designed anaerobically curable compositions using the following trithiadiaza pentalenes as a cure accelerator:
  • Figure US20090022894A1-20090122-C00004
  • where A and A1 may be selected from O and N; and
  • R, R1, R2 and R3 may be the same or different, are as defined above and cycloalkyl, cycloalkenyl, and aryl, having from 1 to about 30 carbon atoms, and may be substituted or interrupted with a heteroatom, and heterocyclic structures, or
  • R1 and R3 taken together may join to form a cyclic structure having from about 20 to about 28 ring atoms, and together represent dialkyl substituted polyether structures that may be substituted or interrupted with the trithiadiaza pentalene structure, which itself may or may not be substituted by A1, R2, or R3, as defined above. See U.S. Pat. No. 6,583,289 (McArdle).
  • Triazine/thiol anaerobic cure systems may also be used in the practice of the present invention. For instance, U.S. Pat. Nos. 4,413,108, 4,447,588, 4,500,608 and 4,528,059, each speak to such a system, and the entirety of each of which is hereby expressly incorporated herein by reference.
  • The inventive compositions may also include other conventional components, such as metal catalysts, like iron and copper. Metal catalysts are generally undesirable in one-part anaerobic formulations (hence the use of sequestering agents to precipitate metals). In two-part anaerobic formulations, metal catalysts may be added to part of the formulation that does not contain an initiator, such as a peroxy compound.
  • A number of well-known initiators of free radical polymerization are typically incorporated into the inventive compositions including, without limitation, hydroperoxides, such as CHP, para-menthane hydroperoxide, t-butyl hydroperoxide (“TBH”) and t-butyl perbenzoate. Other peroxides include benzoyl peroxide, dibenzoyl peroxide, 1,3-bis(t-butylperoxyisopropyl)benzene, diacetyl peroxide, butyl 4,4-bis(t-butylperoxy)valerate, p-chlorobenzoyl peroxide, cumene hydroperoxide, t-butyl cumyl peroxide, t-butyl perbenzoate, di-t-butyl peroxide, dicumyl peroxide, 2,5-dimethyl-2,5-di-t-butylperoxyhexane, 2,5-dimethyl-2,5-di-t-butyl-peroxyhex-3-yne, 4-methyl-2,2-di-t-butylperoxypentane and combinations thereof.
  • The anaerobic cure-inducing composition may be used in amounts of about 0.1 to about 10 weight percent, such as about 1 to about 5 weight percent, based on the total weight of the composition.
  • Additional components have been included in traditional anaerobic curable compositions to alter the physical properties of either the curable compositions or the reaction products thereof. For instance, thickeners, non-reactive plasticizers, fillers, toughening components (such as elastomers and rubbers), and other well-known additives may be incorporated therein where the art-skilled person believes it would be desirable to do so.
  • In addition, it may be desirable to control the strength over a certain in service temperature range. In such a case, one may wish to add a coreactant to the composition. Such a coreactant may be chosen from those disclosed and described in U.S. Pat. Nos. 6,043,327 (Attarwala) and 6,391,993 (Attarwala), the disclosures of each of which being expressly incorporated herein by reference.
  • For instance with reference to the '327 and '993 patents, the coreactant may be selected from
  • Figure US20090022894A1-20090122-C00005
  • where in structure I, X can be present at least once (i.e., mono-, di, or tri-substituted) and may be chosen from H or DnA, where n can range between 0 and 1, with at least one X being DnA. Do if present (i.e., if n=1), can be attached to the ring and can be chosen from O, S, or NH. A can be attached to D (if present) or directly to the ring (if D is not present, i.e., n=0). A can be represented by structure III below:
  • Figure US20090022894A1-20090122-C00006
  • where E can be a member selected from H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to 20 carbon atoms with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate. R can be selected from H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to about 20 carbon atoms, with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate.
  • X1 can be present at least once on structure II (i.e., mono-, di-, or tri-substituted) and may be chosen from H or O═CDnA, with at least one X1 being O═CDnA, where Dn and A can be as defined above.
  • Another suitable coreactant can be represented as:
  • Figure US20090022894A1-20090122-C00007
  • where D and A can be as described above and can be present at least once and can also be present together attached to ring atoms which are in alpha-beta relation to one another.
  • Examples of particular coreactant include, but are not limited to, those shown in formulas V-VII below.
  • Figure US20090022894A1-20090122-C00008
  • Of the coreactants represented above, particularly desirable ones are represented below by structures V [triallyl cyanurate (“TAC”)], VI [triallyl trimesate (“TAT-”)], and VII [triallyl isocyanurate (“TAI”)].
  • The present invention also provides methods of preparing and using the inventive anaerobic adhesive compositions, as well as reaction products of the compositions.
  • The compositions of the present invention may be prepared using conventional methods which are well known to those persons of skill in the art. For instance, the components of the inventive compositions may be mixed together in any convenient order consistent with the roles and functions the components are to perform in the compositions. Conventional mixing techniques using known apparatus may be employed.
  • The compositions of this invention may be applied to a variety of substrates to perform with the desired benefits and advantages described herein. For instance, appropriate substrates may be constructed from steel, brass, copper, aluminum, zinc, glass and other metals and alloys, ceramics and thermosets. The inventive compositions may have beneficial properties making them suitable for use in gasketing and composite applications. The compositions of this invention demonstrate particularly good bond strength on steel and aluminum. An appropriate primer may be applied to a surface of the chosen substrate to enhance the cure rate of the inventive compositions. See e.g. U.S. Pat. No. 5,811,473 (Ramos).
  • The invention also provides a process for preparing a reaction product from the anaerobic adhesive composition of the present invention, steps of which include applying the composition to a desired substrate surface and exposing the composition to an anaerobic environment for a time sufficient to cure the composition.
  • In view of the above description of the present invention, it is clear that a wide range of practical opportunities is provided. The following examples are provided for illustrative purposes only, and are not to be construed so as to limit in any way the teaching herein.
  • EXAMPLES Example 1
  • Initially, we evaluated LOCTITE 272 with and without boric acid at different levels to determine relative hot strength values.
  • LOCTITE 272 is made from an aromatic dimethacrylate ester (CAS No. 24448-20-2) in an amount between 60-100% maleimide resin (CAS No. 3006-93-7) in an amount between 10-30%, hydroxyalkyl methacrylate (CAS No. 27813-02-1) in an amount between 1-5%, cumene hydroperoxide (CAS No. 80-15-9), in an amount between 1-5%, silica (amorphous, fumed, crystalline-free) (CAS No. 112945-52-5) in an amount between 1-5%, and APH (CAS No. 114-83-0) in an amount between 0.1-1%.
  • In Table 1 below, LOCTITE 272 was used as one control and is referred to as Sample No. 1. Sample Nos. 2-4 were formulated with LOCTITE 272 and the amount of boric acid shown.
  • TABLE 1
    % Boric
    Sample No. Acid
    1 0
    2 5
    3 25
    4 50
  • With reference to Table Nos. 2 and 3 below, it may be seen that upon application to steel nuts and bolts Sample No. 1 demonstrated 107 in-lbs of breakaway strength after 4 hours at a temperature of 300° C. and only 12 in-lbs breakaway hot strength after 20 hours at a temperature of 300° C. At a temperature of 350° C., however, upon application to steel nuts and bolts Sample No. 1 demonstrated 26 in-lbs of breakaway strength after 4 hours at a temperature of 350° C. but no breakaway hot strength after 20 hours at a temperature of 350° C. Thus, in terms of retained strength, Sample No. 1 showed only 66 at 300° C. after the given time period and no retained strength at all at 350° C. after the given time period.
  • Each of Sample Nos. 2, 3, and 4 demonstrated an increased retention in hot strength at higher temperatures and longer ageing times, as compared to Sample No. 1. The significant improvement in percent hot strength retained at each of 300° C. and 350° C. heat ageing of Sample Nos. 3 and 4 are attributed in this invention to the 25% and 50% by weight, respectively, of boric acid in the samples.
  • TABLE 2
    Breakaway Breakaway % Hot Strength
    Strength, Strength, Retained @ 300° C.,
    Sample in-lbs in-lbs 20 hrs (vs. 100%
    No. After RTC 24 hrs @ 300° C., 20 Hrs Initial Strength)
    1 201 12 6
    2 210 17 8
    3 175 56 30
    4 213 60 30
  • TABLE 3
    Breakaway Breakaway % Hot Strength
    Strength, in- Strength, in- Retained @ 350° C.,
    Sample lbs lbs 20 hrs (vs. 100%
    No. After RTC 24 hrs @ 350° C., 20 Hrs Initial Strength)
    1 201 No strength 0
    2 210 No strength 0
    3 175 12 7
    4 213 38 18
  • In Table 4, Sample No. 5, LOCTITE PST 567, is used as one control, and Sample No. 6, PST with boric acid, is used as a second control. Sample Nos. 7-10 are shown with various weight percentages of boric acid added thereto.
  • TABLE 4
    Sample No./Amt (wt %)
    Components 5 6 7 8 9 10
    (Meth)acrylate Anaerobic 80 76 72 60 40 32
    Cure Component
    Thickeners
    20 19 18 15 10 8
    Boric Acid 0 5 10 25 50 60
  • TABLE 5A
    % Hot Strength
    Retained,
    Breakloose 350° C. 3 days,
    Strength, test @ 350° C. (vs.
    Sample in-lbs 100% Initial
    No. After RTC 24 hrs Strength)
    5 90 30%
    6 96 33%
    7 89 39%
    9 94 52%
    10 126 173%
  • Sample Nos. 5-7 and 9-10 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 350° C. for a period of time of 3 days. Table 5A shows evaluation results, with Sample Nos. 9 and 10 demonstrating more than 50% hot strength retained under the test conditions, while Sample Nos. 5, 6 and 7 demonstrated below 40% hot strength retained under the same conditions.
  • TABLE 5B
    % Hot Strength
    Retained,
    Breakloose 280° C. 3 days,
    Strength, test @ 280° C. (vs.
    Sample in-lbs 100% Initial
    No. After RTC 24 hrs Strength)
    5 45 80
    6 32 119
    8 49 134
  • Sample Nos. 5, 6 and 8 were evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 280° C. for a period of time of 24 hours. Table 5B shows evaluation results, with Sample No. 6 and 8 demonstrating over 100% hot strength retained at a temperature of 280° C. after a period of time of 24 hours, while Sample No. 5 demonstrated 80% hot strength retained under the same conditions.
  • TABLE 5C
    % Hot Strength
    Retained,
    Breakloose 350° C. 3 days,
    Strength, test @ 350° C. (vs.
    Sample in-lbs 100% Initial
    No. After RTC 24 hrs Strength)
    6 84 82
    7 103 79
    8 81 133
    10 150 132
  • Sample Nos. 6, 7, 8 and 10 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of at 350° C. for a period of time of 24 hours Table 5C shows evaluation results of Sample Nos. 8 and 10 demonstrating more than 100% hot strength retained at 350° C. after hours, Sample Nos. 6 and 7 demonstrated less than less than 90% strength retained at the same conditions.
  • In Table 6 below, Example 3 from Table 1 at column 14 of U.S. Pat. No. 6,043,327, representative of LOCTITE 294, is reproduced as Sample No. 11 and a formulation within the scope of the invention is shown as Sample No. 12.
  • TABLE 6
    Sample No./
    Amt (wt %)
    Components 11* 12
    Polyethyleneglycol Dimethacrylate 60 20
    Trially Cyanurate (“TAC”) 20 26
    Maleimide 15
    Polyethylene powder  3
    Thickeng agents  5
    Boric acid 44
    *From Table 1 of U.S. Pat. No. 6,043,327; the anaeobic cure system for this system is described at column 14, lines 31-50. A comparable anaerobic cure system is used in Sample No. 12. The balance to reach 100 weight percent is made up from the anaerobic cure system.
  • Sample No. 11, representative of LOCTITE 294, is used as a control and contains the combination of maleimide and TAC for controlled strength heat resistance, while Sample No. 12 contains the combination of boric acid and TAC for heat resistance.
  • TABLE 7
    Temperature Sample No.
    (° C.) 11 12
    RTC control 121 131
    150 144 102
    200 111 98
    233 80 91
    260 59 103
    300 28 50
    350 93
  • Reference to Table 7 shows the hot breakloose strength of Sample No. 11 decreased at a temperature above 233° C., while the hot strength of Sample No. 12 was retained at temperatures up to 350° C. Reference also to FIG. 1 shows this data graphically, and highlights that the strength is by and large maintained over the temperature range evaluated.
  • Table No. 8 below shows a comparison of two samples, one with silicic acid (Sample No. 13) and the other (Sample No. 5) as a control, without silicic acid.
  • TABLE 8
    Sample No./
    Amt (wt %)
    Component 5 13
    (Meth)acrylate Anaerobic 80 66
    Cure Component
    Thickeners
    20 10
    Silicic Acid 0 26
  • TABLE 9
    % Hot Strength
    Retained
    350° C. 3 days,
    Breakloose, test @ 350° C. (vs.
    Sample in-lbs 100% Initial
    No. After RTC 24 hrs Strength)
    5 90 30
    12 126 100
  • With reference to Table 8, Sample No. 13 was also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 350° C. for a period of time of 3 days. Table 9 shows evaluation results, with Sample No. 13 surprisingly demonstrating 100% hot strength retained at 350° C. after 3 days, while Sample No. 5 demonstrated only 30% hot strength under the same conditions.
  • With reference to Table 10, Sample Nos. 13 and 14 are presented, with Sample No. 14 being LOCTITE 510 Gasket Eliminator Flange Sealant and Sample No. 15 being 75% by weight LOCTITE 510 Gasket Eliminator Flange Sealant and 25% by weight sodium silicate powder.
  • TABLE 10
    Sample No./
    Amt (wt %)
    Components 13 14
    LOCTITE 510 Gasket 100 75
    Eliminator Flange Sealant*
    Sodium silicate, powder 0 25
    *Polyglycol dimethacrylate, 30-60%, bisphenol A fumarate resin, 10-30%, 4,4′-diphneylmethanebismaleimide, 5-10%, silica, 1-5%, saccharin, 1-5%, cumene hydroperoxide, 1-5, and APH, 0.1-1%.
  • TABLE 11
    % Hot Strength
    Retained,
    233° C. 3 days,
    Breakloose test @ 233° C.
    Strength, (vs. 100%
    Sample in-lbs Initial
    No. After RTC 24 hrs Strength)
    13 186 27
    14 104 46
  • Sample Nos. 13 and 14 were also evaluated on stainless steel nut and bolt assemblies, pre-torqued to 44 in-lbs, at a temperature of 233° C. for a period of time of 24 hours. Table 11 shows the evaluation results, with Sample No. 14 demonstrating improved strength retained at 233° C. for a period of time of 24 hours as compared to Sample No. 13.

Claims (12)

1. An anaerobic curable composition, comprising:
(a) a (meth)acrylate component;
(b) an anaerobic cure system; and
(c) a component comprising the structural unit, MO—X(Y)—OM′, wherein M and M′ are independently selected from the group consisting of hydrogen, sodium, potassium, and lithium, X is silicon or boron, and Y is ═O, when X is silicon and v is OH, when X is boron, provided that when Y is OH, when X is boron, the component is present in an amount within the range of about 25 weight percent to 75 weight percent.
2. The composition according to claim 1, wherein X in the component is boron, and is present in an amount within the range of about 35 weight percent to 60 weight percent.
3. The composition according to claim 1, wherein X in the component is boron, and is present in an amount within the range of about 40 weight percent to 50 weight percent.
4. The composition according to claim 1, wherein the (meth)acrylate component is represented by H2C═CGCO2R1, wherein G is a member selected from the group consisting of H, halogen and alkyl having from 1 to about four carbon atoms, and R1 is a member selected from the group consisting of alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkaryl, and aryl groups having from 1 to about 16 carbon atoms, with or without substitution or interruption by a member selected from the group consisting of silane, silicon, oxygen, halogen, carbonyl, hydroxyl, ester, carboxylic acid, urea, urethane, carbamate, amine, amide, sulfur, sulfonate and sulfone.
5. The composition according to claim 1, wherein the (meth)acrylate component selected from the group consisting of silicone (meth)acrylates, polyethylene glycol di(meth)acrylates, bisphenol-A-(methacrylates, ethoxylated bisphenol-A-(meth)acrylates, bisphenol-F-(meth)acrylates, ethoxylated bisphenol-F-(meth)acrylates, tetrahydrofuran (meth)acrylates and di(meth)acrylates, hydroxypropyl(meth)acrylate, hexanediol di(meth)acrylate, and trimethylol propane tri(meth)acrylate.
6. The composition according to claim 1, wherein the anaerobic cure system comprises one or more of the following:
A. the combination of saccharin, toluidines, acetyl phenylhydrazine, maleic acid, and quinones;
B.
Figure US20090022894A1-20090122-C00009
wherein R1, R2 and R3 are each independently selected from the group consisting of hydrogen or C1-4; Z is a carbon-carbon single bond or carbon-carbon double bond; m is 0 or 1; and n is an integer between 1 and 5;
C.
Figure US20090022894A1-20090122-C00010
wherein Y is selected from the group consisting of an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups; A is C═O, S═O or O═S═O; X is NH, O or S and Z is an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups, or Y and Z taken together may join to the same aromatic ring or aromatic ring system, provided that when X is NH, o-benzoic sulfimide is excluded therefrom;
D.
Figure US20090022894A1-20090122-C00011
wherein R is selected from the group consisting of hydrogen, halogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, carboxyl, or sulfonato, and R1 is as defined above and alkenyl, hydroxyalkyl, hydroxyalkenyl, or aralkyl;
E. trithiadiaza pentalenes embraced by the following structure:
Figure US20090022894A1-20090122-C00012
wherein A and A′ are each independently selected from the group consisting of O and N; and
R, R1, R2 and R3 are the same or different, are as defined above and cycloalkyl, cycloalkenyl, and aryl, having from 1 to about 30 carbon atoms, and may be substituted or interrupted with a heteroatom, and heterocyclic structures, or
R1 and R3 taken together may join to form a cyclic structure having from about 20 to about 28 ring atoms, and together represent dialkyl substituted polyether structures that may be substituted or interrupted with the trithiadiaza pentalene structure, which itself may or may not be substituted by A1, R2 or R3, as defined above; and
F. the combination of a triazine and a thiol.
7. The composition according to claim 1, further comprising a coreactant.
8. The composition according to claim 7, wherein the coreactant is selected from the group consisting of
Figure US20090022894A1-20090122-C00013
wherein in structure I, X is present at least once and is chosen from H or DnA, wherein n can range between 0 and 1, with at least one X being DnA, wherein D can be attached to the ring and can be chosen from O, S, or NH and A is attached to D (if present) or directly to the ring, wherein A is represented by structure III below:
Figure US20090022894A1-20090122-C00014
wherein E is a member selected from the group consisting of H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to 20 carbon atoms with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate, wherein R is selected from the group consisting of H, linear, branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or aryl groups, having from 1 to about 20 carbon atoms, with or without substitution by halogen, silicon, hydroxy, nitrile, ester, amide or sulfate;
wherein in structure II, X1 is present at least once and is chosen from H or O═CDnA, with at least; one X1 being O═CDnA, wherein D, and A are as defined above; and
wherein in structure III, D and A are as described above and are present at least once and can also be present together attached to rind atoms which are in alpha-beta relation to one another.
9. The composition according to claim 8, wherein the coreactant is
Figure US20090022894A1-20090122-C00015
10. Reaction products of the composition according to claim 1.
11. A process for preparing a reaction product from an anaerobic curable composition, comprising the steps of:
apply an anaerobic curable composition according to claim 1, to a desired substrate surface and
exposing the composition to an anaerobic environment for a time sufficient to cure the composition.
12. A composition comprising a bond formed between two mated substrates with the composition of claim 1.
US11/778,190 2007-07-16 2007-07-16 Thermally Resistant Anaerobically Curable Compositions Abandoned US20090022894A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US11/778,190 US20090022894A1 (en) 2007-07-16 2007-07-16 Thermally Resistant Anaerobically Curable Compositions
CA2691947A CA2691947C (en) 2007-07-16 2008-07-14 Thermally resistant anaerobically curable compositions
PCT/US2008/008582 WO2009011819A2 (en) 2007-07-16 2008-07-14 Thermally resistant anaerobically curable compositions
JP2010516998A JP5697977B2 (en) 2007-07-16 2008-07-14 Heat resistant anaerobically curable composition
KR1020107003244A KR101520513B1 (en) 2007-07-16 2008-07-14 Thermally resistant anaerobically curable compositions
CN200880024813.7A CN101743260B (en) 2007-07-16 2008-07-14 The anaerobically curable compositions of thermotolerance
US15/145,167 US10100226B2 (en) 2007-07-16 2016-05-03 Thermally resistant anaerobically curable compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/778,190 US20090022894A1 (en) 2007-07-16 2007-07-16 Thermally Resistant Anaerobically Curable Compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/145,167 Continuation US10100226B2 (en) 2007-07-16 2016-05-03 Thermally resistant anaerobically curable compositions

Publications (1)

Publication Number Publication Date
US20090022894A1 true US20090022894A1 (en) 2009-01-22

Family

ID=40260250

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/778,190 Abandoned US20090022894A1 (en) 2007-07-16 2007-07-16 Thermally Resistant Anaerobically Curable Compositions
US15/145,167 Active 2027-09-18 US10100226B2 (en) 2007-07-16 2016-05-03 Thermally resistant anaerobically curable compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/145,167 Active 2027-09-18 US10100226B2 (en) 2007-07-16 2016-05-03 Thermally resistant anaerobically curable compositions

Country Status (6)

Country Link
US (2) US20090022894A1 (en)
JP (1) JP5697977B2 (en)
KR (1) KR101520513B1 (en)
CN (1) CN101743260B (en)
CA (1) CA2691947C (en)
WO (1) WO2009011819A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011047123A3 (en) * 2009-10-15 2011-09-15 Henkel Corporation Anaerobically curable compositions
US20140053174A1 (en) * 2012-08-15 2014-02-20 Sony Corporation Broadband delivery of personalization information for advanced tv services

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012086445A1 (en) * 2010-12-24 2014-05-22 スリーボンドファインケミカル株式会社 Anaerobic curable composition
CN102604547A (en) * 2012-02-23 2012-07-25 北京天山新材料技术股份有限公司 High-temperature resistant anaerobic locking glue and preparation method thereof
KR20150035748A (en) * 2012-05-30 2015-04-07 헨켈 유에스 아이피 엘엘씨 Resin compositions for coating substrates to improve sealing performance
CN104152086B (en) * 2014-08-08 2017-01-18 黑龙江省科学院石油化学研究院 Modified acrylate high temperature-resistant anaerobic adhesive and preparation method thereof
CA2981703C (en) * 2015-04-03 2023-08-22 Henkel IP & Holding GmbH Anaerobic curable compositions
TWI738730B (en) * 2016-03-29 2021-09-11 德商漢高智慧財產控股公司 Two part curable compositions

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218305A (en) * 1963-12-26 1965-11-16 Loctite Corp Accelerated anaerobic compositions and method of using same
US3988299A (en) * 1974-10-10 1976-10-26 Loctite Corporation Anaerobic adhesive composition having improved strength at elevated temperature consisting of unsaturated diacrylate monomer and maleimide additive
US4180640A (en) * 1976-11-08 1979-12-25 Loctite Corporation Accelerator for curable acrylic ester compositions
US4287330A (en) * 1975-05-23 1981-09-01 Loctite Corporation Accelerator for curable compositions
US4320221A (en) * 1980-12-12 1982-03-16 The Dow Chemical Company Addition polymerizable isocyanate-polyol anaerobic adhesives
US4321349A (en) * 1975-05-23 1982-03-23 Loctite Corporation Accelerator for curable compositions
US4413108A (en) * 1980-11-03 1983-11-01 Minnesota Mining & Manufacturing Company Anaerobically-curing compositions
US4447588A (en) * 1980-11-03 1984-05-08 Minnesota Mining & Manufacturing Company Anaerobically-curing compositions
US4451627A (en) * 1982-09-07 1984-05-29 The Dow Chemical Company Addition polymerizable urethane-based anaerobic adhesives made from tin (II) organoesters
US4500608A (en) * 1980-11-03 1985-02-19 Minnesota Mining And Manufacturing Company Anaerobically-curing compositions
US4528059A (en) * 1981-08-03 1985-07-09 Minnesota Mining & Manufacturing Company Anaerobically-cuting compositions
US4546125A (en) * 1983-05-12 1985-10-08 Okura Kogyo Kabushiki Kaisha Anaerobic curing adhesive compositions
US5605999A (en) * 1995-06-05 1997-02-25 Loctite Corporation Anaerobically curable silicones
US5811473A (en) * 1996-04-02 1998-09-22 Loctite Corporation Primer activator composition for anaerobic adhesives
US6043327A (en) * 1997-07-03 2000-03-28 Loctite Corporation Anaerobic adhesive compositions of acrylates coreactants and maleimides curable under ambient conditions
US6150479A (en) * 1998-11-23 2000-11-21 Loctite Corporation Radical-curable adhesive compositions, reaction products of which demonstrate superior resistance to thermal degradation
US6342545B1 (en) * 1998-11-23 2002-01-29 Loctite Corporation Radical-curable adhesive compositions, reaction products of which demonstrate superior resistance to thermal degradation
US6583289B1 (en) * 1999-01-08 2003-06-24 Loctite (R&D) Limited Curative for anaerobic adhesive compositions
US6835762B1 (en) * 2002-05-31 2004-12-28 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6852778B1 (en) * 1999-06-11 2005-02-08 Three Bond Co., Ltd. Anaerobically curable composition
US6897277B1 (en) * 2003-12-22 2005-05-24 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6958368B1 (en) * 2002-05-31 2005-10-25 Henkel Corporation Cure accelerators for anaerobic curable compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5582157A (en) * 1978-12-18 1980-06-20 Asahi Chem Ind Co Ltd Curable molding compound
ATE19891T1 (en) * 1981-12-09 1986-06-15 Lingner & Fischer Gmbh CURING MASS.
JPS61185573A (en) * 1985-02-12 1986-08-19 Chisso Corp Curable composition
JP2815233B2 (en) 1990-01-08 1998-10-27 大倉工業株式会社 Anaerobic adhesive
JPH0853506A (en) * 1994-08-11 1996-02-27 Okura Ind Co Ltd Curing method for air contacting surface of anerobic curing composition
AU731141B2 (en) * 1997-07-03 2001-03-22 Loctite Corporation High temperature, controlled strength anaerobic adhesive compositions curable under ambient environmental conditions
US20060047046A1 (en) * 2004-08-30 2006-03-02 Illinois Tool Works, Inc. Thixotropic anaerobic adhesive
JP2006104312A (en) * 2004-10-05 2006-04-20 Three Bond Co Ltd Precoating type adhesive composition

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218305A (en) * 1963-12-26 1965-11-16 Loctite Corp Accelerated anaerobic compositions and method of using same
US3988299A (en) * 1974-10-10 1976-10-26 Loctite Corporation Anaerobic adhesive composition having improved strength at elevated temperature consisting of unsaturated diacrylate monomer and maleimide additive
US4287330A (en) * 1975-05-23 1981-09-01 Loctite Corporation Accelerator for curable compositions
US4321349A (en) * 1975-05-23 1982-03-23 Loctite Corporation Accelerator for curable compositions
US4180640A (en) * 1976-11-08 1979-12-25 Loctite Corporation Accelerator for curable acrylic ester compositions
US4500608A (en) * 1980-11-03 1985-02-19 Minnesota Mining And Manufacturing Company Anaerobically-curing compositions
US4413108A (en) * 1980-11-03 1983-11-01 Minnesota Mining & Manufacturing Company Anaerobically-curing compositions
US4447588A (en) * 1980-11-03 1984-05-08 Minnesota Mining & Manufacturing Company Anaerobically-curing compositions
US4320221A (en) * 1980-12-12 1982-03-16 The Dow Chemical Company Addition polymerizable isocyanate-polyol anaerobic adhesives
US4528059A (en) * 1981-08-03 1985-07-09 Minnesota Mining & Manufacturing Company Anaerobically-cuting compositions
US4451627A (en) * 1982-09-07 1984-05-29 The Dow Chemical Company Addition polymerizable urethane-based anaerobic adhesives made from tin (II) organoesters
US4546125A (en) * 1983-05-12 1985-10-08 Okura Kogyo Kabushiki Kaisha Anaerobic curing adhesive compositions
US5605999A (en) * 1995-06-05 1997-02-25 Loctite Corporation Anaerobically curable silicones
US5811473A (en) * 1996-04-02 1998-09-22 Loctite Corporation Primer activator composition for anaerobic adhesives
US6043327A (en) * 1997-07-03 2000-03-28 Loctite Corporation Anaerobic adhesive compositions of acrylates coreactants and maleimides curable under ambient conditions
US6391993B1 (en) * 1997-07-03 2002-05-21 Loctite Corporation High temperature, controlled strength anaerobic compositions curable under ambient environmental conditions
US6342545B1 (en) * 1998-11-23 2002-01-29 Loctite Corporation Radical-curable adhesive compositions, reaction products of which demonstrate superior resistance to thermal degradation
US6150479A (en) * 1998-11-23 2000-11-21 Loctite Corporation Radical-curable adhesive compositions, reaction products of which demonstrate superior resistance to thermal degradation
US6583289B1 (en) * 1999-01-08 2003-06-24 Loctite (R&D) Limited Curative for anaerobic adhesive compositions
US6852778B1 (en) * 1999-06-11 2005-02-08 Three Bond Co., Ltd. Anaerobically curable composition
US6835762B1 (en) * 2002-05-31 2004-12-28 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6958368B1 (en) * 2002-05-31 2005-10-25 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6897277B1 (en) * 2003-12-22 2005-05-24 Henkel Corporation Cure accelerators for anaerobic curable compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011047123A3 (en) * 2009-10-15 2011-09-15 Henkel Corporation Anaerobically curable compositions
CN102549059A (en) * 2009-10-15 2012-07-04 汉高公司 Anaerobically curable compositions
US9580530B2 (en) 2009-10-15 2017-02-28 Henkel IP & Holding GmbH Anaerobically curable compositions
US20140053174A1 (en) * 2012-08-15 2014-02-20 Sony Corporation Broadband delivery of personalization information for advanced tv services

Also Published As

Publication number Publication date
CN101743260B (en) 2015-12-16
KR101520513B1 (en) 2015-05-21
CA2691947C (en) 2016-05-24
US20160319162A1 (en) 2016-11-03
CA2691947A1 (en) 2009-01-22
US10100226B2 (en) 2018-10-16
KR20100046009A (en) 2010-05-04
WO2009011819A3 (en) 2009-03-05
WO2009011819A2 (en) 2009-01-22
JP2010533768A (en) 2010-10-28
CN101743260A (en) 2010-06-16
JP5697977B2 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
US10100226B2 (en) Thermally resistant anaerobically curable compositions
US9580530B2 (en) Anaerobically curable compositions
US9957344B2 (en) Anaerobic curable compositions having novolac vinyl esters
US8945338B2 (en) Anaerobic curable compositions
US9994510B2 (en) Anaerobic curable compositions containing blocked (meth)acrylic acid compounds
CA2703865C (en) Thermally resistant anaerobically curable compositions
US7951884B1 (en) Cure accelerators for anaerobic adhesive compositions
US11274190B2 (en) Cure accelerators for anaerobic curable compositions
US6723763B2 (en) Cure accelerators for anaerobic adhesive compositions
US10662147B2 (en) Phenylhydrazine/anhydride adducts and anaerobic curable compositions using same
EP3204461B1 (en) Cure accelerators for anaerobic curable compositions
US20210171810A1 (en) Two Step Adhesive System
US7709559B1 (en) Cure accelerators for anaerobic curable compositions
US8034851B1 (en) Anaerobic cure systems for an anaerobic curable compositions, and anaerobic curable compositions containing same
EP4200344A1 (en) Cure accelerators for anaerobic curable compositions

Legal Events

Date Code Title Description
AS Assignment

Owner name: HENKEL CORPORATION, CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ATTARWALA, SHABBIR;ZHU, QINYAN;REEL/FRAME:019560/0135;SIGNING DATES FROM 20070713 TO 20070716

AS Assignment

Owner name: HENKEL CORPORATION, CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCHINDLER, KLAUS;REEL/FRAME:019676/0553

Effective date: 20070727

AS Assignment

Owner name: HENKEL US IP LLC, CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HENKEL CORPORATION;REEL/FRAME:034183/0611

Effective date: 20141106

AS Assignment

Owner name: HENKEL IP & HOLDING GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HENKEL US IP LLC;REEL/FRAME:035100/0151

Effective date: 20150225

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION